United States · Series B startup
4 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$52Mraised across 4 rounds since 2007, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
Reported by traconpharma.comSEC filing: $17M sold, first sale Mar 2011
No investor was named in the report.
From a historical funding recordSEC filing: $1.5M sold, first sale Mar 2010
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Enterprise Associates
JAFCOJafco Ventures
Nextech InvestBioMed VenturesBrookline Venture PartnersMissing a round, or an investor who was in one? Tell us.
TRACON Pharmaceuticals's investors include Arcus Ventures, New Enterprise Associates, JAFCO, Jafco Ventures and Nextech Invest, and 2 more on record.
TRACON Pharmaceuticals has raised $52M across 4 rounds since 2007.
TRACON Pharmaceuticals's most recent round was a Series B of $27M in Sept 2014.
Its most recent round, $27M in Sept 2014, is also its largest on record.
TRACON Pharmaceuticals's first round on record, in Apr 2011, was backed by Jafco Ventures and Arcus Ventures.
TRACON Pharmaceuticals's latest named round is a Series B, in Sept 2014.
TRACON Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·